GB779257A - Improvements in or relating to antibiotics and the preparation thereof - Google Patents

Improvements in or relating to antibiotics and the preparation thereof

Info

Publication number
GB779257A
GB779257A GB14544/54A GB1454454A GB779257A GB 779257 A GB779257 A GB 779257A GB 14544/54 A GB14544/54 A GB 14544/54A GB 1454454 A GB1454454 A GB 1454454A GB 779257 A GB779257 A GB 779257A
Authority
GB
United Kingdom
Prior art keywords
per cent
meal
oleandomycin
chloroform
hydrochloride
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired
Application number
GB14544/54A
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Pfizer Inc
Original Assignee
Pfizer Inc
Charles Pfizer and Co Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Pfizer Inc, Charles Pfizer and Co Inc filed Critical Pfizer Inc
Publication of GB779257A publication Critical patent/GB779257A/en
Expired legal-status Critical Current

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12NMICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N1/00Microorganisms, e.g. protozoa; Compositions thereof; Processes of propagating, maintaining or preserving microorganisms or compositions thereof; Processes of preparing or isolating a composition containing a microorganism; Culture media therefor
    • C12N1/20Bacteria; Culture media therefor
    • C12N1/205Bacterial isolates
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07KPEPTIDES
    • C07K7/00Peptides having 5 to 20 amino acids in a fully defined sequence; Derivatives thereof
    • C07K7/50Cyclic peptides containing at least one abnormal peptide link
    • C07K7/54Cyclic peptides containing at least one abnormal peptide link with at least one abnormal peptide link in the ring
    • C07K7/56Cyclic peptides containing at least one abnormal peptide link with at least one abnormal peptide link in the ring the cyclisation not occurring through 2,4-diamino-butanoic acid
    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12PFERMENTATION OR ENZYME-USING PROCESSES TO SYNTHESISE A DESIRED CHEMICAL COMPOUND OR COMPOSITION OR TO SEPARATE OPTICAL ISOMERS FROM A RACEMIC MIXTURE
    • C12P17/00Preparation of heterocyclic carbon compounds with only O, N, S, Se or Te as ring hetero atoms
    • C12P17/18Preparation of heterocyclic carbon compounds with only O, N, S, Se or Te as ring hetero atoms containing at least two hetero rings condensed among themselves or condensed with a common carbocyclic ring system, e.g. rifamycin
    • C12P17/188Heterocyclic compound containing in the condensed system at least one hetero ring having nitrogen atoms and oxygen atoms as the only ring heteroatoms
    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12PFERMENTATION OR ENZYME-USING PROCESSES TO SYNTHESISE A DESIRED CHEMICAL COMPOUND OR COMPOSITION OR TO SEPARATE OPTICAL ISOMERS FROM A RACEMIC MIXTURE
    • C12P21/00Preparation of peptides or proteins
    • C12P21/02Preparation of peptides or proteins having a known sequence of two or more amino acids, e.g. glutathione

Abstract

<PICT:0779257/IV(b)/1> <PICT:0779257/IV(b)/2> A new antibiotic oleandomycin (originally referred to as PA 106 and also called amimycin) is produced by cultivating Streptomyces antibioticus ATCC 11891, or a mutant thereof, in an aqueous nutrient medium under submerged aerobic conditions until substantial anti-bacterial activity is imparted to the medium. A temperature of 24 DEG to 30 DEG C. and period of 1 to 4 days is suitable. The medium contains (a) a source of carbohydrate, e.g. sugars, starch, glycerol and corn meal; (b) a source of nitrogen, e.g. casein, soybean meal, peanut meal, wheat gluten, cottonseed meal, lactalbumin, enzymatic digest of casein and tryptone; (c) a source of growth substance, e.g. distillers' solubles, yeast extract and molasses fermentation residues; (d) mineral salts such as sodium chloride, potassium phosphate, sodium nitrate, magnesium sulphate; and (e) trace metals such as copper, zinc and iron. A buffer, e.g. calcium carbonate and anti-foaming agent, may be present. After removal of the mycelium a crude product is obtained by drying the residual broth. Oleandomycin is isolated from the liquid broth by (A) solvent extraction or (B) adsorption. Solvent extraction is at pH 6 to 10 by means of water-immiscible solvents such as diethyl ether, benzene, toluene, ethyl acetate, butyl acetate, methyl isobutyl ketone, butanol and chloroform. Purification is obtained by treating the extract with water of below pH 2.5 and re-extracting the solution with the organic solvent as pH 6 to 10. The anti-biotic may be recrystallized from ethyl acetate, chloroform methylene chloride or ethylene dichloride. Adsorption is on (a) charcoal, (b) ion-exchange resin, or (c) alumina. Oleandomycin is a basic white amorphous compound; effective in inhibiting the growth of gram-positive bacteria and mycobacteria; forms salts with acids such as hydrochloric, sulphuric and phosphoric acid; soluble in water, methyl alcohol, ethyl alcohol, acetone and butanol, insoluble in hexane, carbon tetrachloride and di-n-butyl ether; the crystalline hydrochloride (a) melts at 134 DEG to 135 DEG C.; (b) contains 57.63 per cent carbon, 8.73 per cent hydrogen, 1.87 per cent nitrogen, 4.30 per cent chlorine and 27.47 per cent oxygen, probably C35H67NO12.HCl; (c) exhibits a broad, low intensity peak in the ultra-violet region at 286-289 mm ; (d) suspended in a potassium bromide pellet shows peaks in the infra-red at the following frequencies: 3380, 2940, 2890, 1710, 1640, 1465, 1380, 1330, 1190, 1160, 1115, 1075, 1055, 1010, 985, 935, 865 and 828 cm-1, hydrochloride dissolved in methanol: <FORM:0779257/IV(b)/1> molecular weight of base is approximately 715; in chloroform the base exhibits characteristic absorption in infra-red at 3510, 2910, 2890, 2840, 2790, 1710, 1460, 1385, 1335, 1305, 1280, 1180, 1160, 1110, 1075, 1050, 1005, 985, 960, 935, 895, 885 and 886 cm.-1. Hydrochloride may be produced by passing hydrogen chloride gas into an acetone solution of the base.
GB14544/54A 1953-06-01 1954-05-18 Improvements in or relating to antibiotics and the preparation thereof Expired GB779257A (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US779257XA 1953-06-01 1953-06-01

Publications (1)

Publication Number Publication Date
GB779257A true GB779257A (en) 1957-07-17

Family

ID=22140824

Family Applications (1)

Application Number Title Priority Date Filing Date
GB14544/54A Expired GB779257A (en) 1953-06-01 1954-05-18 Improvements in or relating to antibiotics and the preparation thereof

Country Status (1)

Country Link
GB (1) GB779257A (en)

Similar Documents

Publication Publication Date Title
US3150059A (en) Penicillin deacylation via actinoplanaceae fermentation
US3178341A (en) Antibiotics tylosin and desmycosin and derivatives thereof
EP0379395B1 (en) Antibiotic L53-18A and process for preparation thereof
US2928844A (en) Celesticetin, its salts and method of preparation
GB1339032A (en) Rabelomycin and processes for its production
GB844289A (en) Pimaricin and process of producing same
US3616228A (en) Beta-substituted propionic acids and method of making the same
GB779257A (en) Improvements in or relating to antibiotics and the preparation thereof
GB765886A (en) A new antibiotic ristocetin and a method of producing same
US3676300A (en) Method for producing monoacyl derivatives of antibiotic t-2636c
US2916483A (en) Methymycin
US3980522A (en) Production of a new antibiotic, calvatic acid
US4009155A (en) P-carboxyphenyl-azoxycarbonitrile and its methyl ester
GB729208A (en) Improvements in or relating to a new antibiotic p.a. 95 and the preparation thereof
US4353986A (en) Process for producing antibiotic nanaomycin E
US3795668A (en) Polyamine compounds and methods for their production
GB1020967A (en) Improvements in or relating to the biochemical production of ribosides or ribotides
GB793797A (en) Improvements in or relating to antibiotics
GB768364A (en) A new antibiotic anisomycin
US4293649A (en) Process for production of antibiotic A-33853
GB764198A (en) The antibiotic vengicide and processes for the preparation of the antibiotics oxytetracycline and vengicide
GB819872A (en) The new antibiotics p.a. 114a and p.a. 114b
US3923979A (en) Antibiotic 60-6 and production thereof
GB708686A (en) Antibiotic d-13 and its production
GB732150A (en) Improvements in or relating to antibiotics